This indicates that SSX2 protein expression may be worthy of further investigation in B-ALL patient samples, and our results suggest a lack of correlation between detectable SSX2 transcription and the presence of SSX2 protein. The gene discussed is SSX2; the disease is precursor B-cell acute lymphoblastic leukemia.